We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYPH
276
Cypherpunk Technologies Inc
CYPH
$70M
– –
-2,500
Closed -$100K
MAPS
277
DELISTED
WM TECHNOLOGY INC A
MAPS
– –
-1,612,498
Closed -$23.4M
MDT icon
278
CALL
Medtronic
MDT
$116B
– –
-120,000
Closed -$15M
MDXG icon
279
MiMedx Group
MDXG
$624M
– –
-1,275,389
Closed -$7.73M
MNKD icon
280
PUT
MannKind Corp
MNKD
$1.24B
– –
-700,000
Closed -$3.04M
DFTX
281
CALL
Definium Therapeutics
DFTX
$5.68B
– –
-14,813
Closed -$518K
MRVI icon
282
Maravai LifeSciences
MRVI
$861M
– –
-77,500
Closed -$3.8M
MRVI icon
283
PUT
Maravai LifeSciences
MRVI
$861M
– –
-77,500
Closed -$3.8M
NEO icon
284
NeoGenomics
NEO
$2.11B
– –
-177,778
Closed -$6.96M
NKTR icon
285
Nektar Therapeutics
NKTR
$2.57B
– –
-14,636
Closed -$3.18M
NTLA icon
286
CALL
Intellia Therapeutics
NTLA
$1.69B
– –
-95,700
Closed -$12.8M
NUVB icon
287
Nuvation Bio
NUVB
$2.25B
– –
-178,403
Closed -$1.77M
ACH
288
PUT
Accendra Health
ACH
$93.1M
– –
-150,000
Closed -$4.69M
PEN icon
289
Penumbra
PEN
$12.9B
– –
-30,000
Closed -$8M
PHG icon
290
PUT
Philips
PHG
$26.2B
– –
-181,593
Closed -$6.67M
PSNL icon
291
Personalis
PSNL
$1.52B
– –
-479,651
Closed -$9.23M
QNCX icon
292
CALL
Quince Therapeutics
QNCX
$31.8M
– –
-1,045
Closed -$19.2M
QTRX icon
293
CALL
Quanterix
QTRX
$139M
– –
-120,000
Closed -$5.97M
RCEL icon
294
Avita Medical
RCEL
$251M
– –
-252,246
Closed -$4.47M
RGEN icon
295
PUT
Repligen
RGEN
$9.35B
– –
-12,500
Closed -$3.61M
RPTX
296
CALL
DELISTED
Repare Therapeutics
RPTX
– –
-50,000
Closed -$1.31M
RPTX
297
DELISTED
Repare Therapeutics
RPTX
– –
-22,143
Closed -$581K
SDGR icon
298
Schrodinger
SDGR
$1.39B
– –
-121,231
Closed -$6.63M
SEER icon
299
Seer Inc
SEER
$118M
– –
-857,306
Closed -$24.7M
SNTI icon
300
Senti Biosciences Holdings
SNTI
$11.7M
– –
-25,570
Closed -$2.54M
10 11
12
13 14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.